Elevated numbers of PD-L1 expressing B cells are associated with the development of AIDS-NHL
Authors:
Open Access
- 28 June 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Abstract
The risk for non-Hodgkin lymphoma (NHL) is markedly increased in persons living with human immunodeficiency virus (HIV) infection, and remains elevated in those on anti-retroviral therapy (cART). Both the loss of immunoregulation of Epstein-Barr virus (EBV) infected cells, as well as chronic B-cell activation, are believed to contribute to the genesis of AIDS-related NHL (AIDS-NHL). However, the mechanisms that lead to AIDS-NHL have not been completely defined. A subset of B cells that is characterized by the secretion of IL10, as well as the expression of the programmed cell death ligand-1 (PD-L1/CD274), was recently described. These PD-L1+ B cells can exert regulatory function, including the dampening of T-cell activation, by interacting with the program cell death protein (PD1) on target cells. The role of PD-L1+ B cells in the development of AIDS-NHL has not been explored. We assessed B cell PD-L1 expression on B cells preceding AIDS-NHL diagnosis in a nested case-control study of HIV+ subjects who went on to develop AIDS-NHL, as well as HIV+ subjects who did not, using multi-color flow cytometry. Archival frozen viable PBMC were obtained from the UCLA Multicenter AIDS Cohort Study (MACS). It was seen that the number of CD19+CD24++CD38++and CD19+PD-L1+cells was significantly elevated in cases 1–4 years prior to AIDS-NHL diagnosis, compared to controls, raising the possibility that these cells may play a role in the etiology of AIDS-NHL. Interestingly, most PD-L1+ expression on CD19+ cells was seen on CD19+CD24++CD38++ cells. In addition, we showed that HIV can directly induce PD-L1 expression on B cells through interaction of virion-associated CD40L with CD40 on B cells.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA168482-S, R21-CA220475, R01-CA196266)
- Division of Intramural Research (P30-AI028697-S)
This publication has 38 references indexed in Scilit:
- Serum Levels of the Chemokine CXCL13, Genetic Variation inCXCL13and Its Receptor CXCR5, and HIV-Associated Non-Hodgkin B-Cell Lymphoma RiskCancer Epidemiology, Biomarkers & Prevention, 2013
- B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS–Associated Non-Hodgkin B-Cell LymphomaCancer Epidemiology, Biomarkers & Prevention, 2011
- HIV-specific CD4 T cells and immune control of viral replicationCurrent Opinion in HIV and AIDS, 2011
- Acquisition of Host-Derived CD40L by HIV-1In Vivoand Its Functional Consequences in the B-Cell CompartmentJournal of Virology, 2011
- Cancer incidence in the multicenter aids cohort study before and during the HAART eraCancer, 2010
- Assessment of Pre-Diagnosis Biomarkers of Immune Activation and Inflammation: Insights on the Etiology of LymphomaJournal of Proteome Research, 2010
- HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphomaImmunologic Research, 2010
- CD40 Ligand (CD154) Incorporated into HIV Virions Induces Activation-Induced Cytidine Deaminase (AID) Expression in Human B LymphocytesPLOS ONE, 2010
- Immunologic and Virologic Predictors of AIDS-Related Non-Hodgkin Lymphoma in the Highly Active Antiretroviral Therapy EraJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Expression and Function of the Chemokine, CXCL13, and Its Receptor, CXCR5, in Aids-Associated Non-Hodgkin's LymphomaAIDS Research and Treatment, 2010